What is ENTYVIO?

ENTYVIO is for adults with moderate to severe ulcerative colitis (UC) or Crohn's disease

Patient Portrayal

#1 PRESCRIBED BIOLOGIC FOR CROHN'S & UC*

*For UC and Crohn's patients combined. Quarterly analysis of claims data from June 2022 – December 2023.

ENTYVIO offers two flexible administration options that support your treatment journey. You and your healthcare provider can select intravenous (IV) infusion or self-administered injection under the skin (subcutaneous).

Ask your healthcare provider about ENTYVIO if you have moderate to severe UC or Crohn’s and one or more of the following applies to you:

  • Certain other ulcerative colitis or Crohn's disease medicines have not worked well enough.
  • Certain other ulcerative colitis or Crohn's disease medicines cannot be tolerated.
  • You rely on steroids to control flare-ups.

ENTYVIO has up to 7 years of safety data from a long-term extension trial.

Crohn's results

See how ENTYVIO helps treat moderate to severe Crohn's disease.

Get the facts

How ENTYVIO works

Curious how ENTYVIO helps fight Crohn's? Here’s an easy-to-understand description.

See the science